Consultancy

With many years of experience in supporting regulatory compliant clinical research, we are ideally placed to advise our clients in making more informed decisions around the selection and use of imaging and digital biomarkers.

We can work as an integral part of our clients' own teams and within collaborative consortia to identify, develop and deliver solutions that reduce risk and increase the impact and value of our clients' assets.

We can define an appropriate imaging strategy to optimise and de-risk deployment into your clinical trial. Our expertise includes structural and functional MRI, PET and SPECT.